Medicine
Exelderm 10 mg/mL topical solution
Exelderm 10 mg/mL topical solution is a prescription medicine containing Sulconazole for topical use, marketed by Journey Medical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
It is supplied as follows: 30 mL plastic bottle – NDC 69489-721-30 Avoid…
Key facts
- Active ingredient (INN)
- Sulconazole
- Brand
- Exelderm
- Strength
- 10 mg/mL
- Dosage form
- Topical solution
- Route
- Topical
- Packs
- 1 bottle
- Marketing authorisation holder
- Journey Medical
- Manufacturer
- Journey Medical
- Origin register
- US FDA, United States
- Storage
- It is supplied as follows: 30 mL plastic bottle – NDC 69489-721-30 Avoid excessive heat, above 40° C (104° F), and protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D01AC09 Sulconazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 June 2019
- Identifiers
- RxCUI 208118, 313125DailyMed set ID 5b73e83e-8d3c-4d96-b4f6-9f854430add8NDC 69489-721Application NDA018738
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 30 mL in 1 bottle | 69489-721-30 | Journey Medical | 7 June 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 August 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sulconazole 10 mg/mL topical solution.
Other strengths and forms of Sulconazole
Clinical summary
Sulconazole is an azole antifungal indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis, and for the treatment of tinea versicolor. MedsAcross supplies Sulconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SulconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sulconazole Nitrate prescribing information (JG Pharma) · U.S. National Library of Medicine, DailyMed
Need Exelderm 10 mg/mL topical solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.